mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |